Jonathan D. Oakley

Deep learning-based prediction of one-year functional and structural outcomes in treatment-naïve DMO after anti-VEGF therapy.

Deep learning analysis of baseline OCT can predict one-year outcomes in DMO, and responder identification suggests the potential utility of this approach for prognostic assessment and risk stratification, warranting further validation before clinical implementation.